{"id":128253,"date":"2025-05-12T05:00:26","date_gmt":"2025-05-12T04:00:26","guid":{"rendered":"https:\/\/easo.org\/?p=128253"},"modified":"2025-05-09T17:46:30","modified_gmt":"2025-05-09T16:46:30","slug":"new-research-presented-live-at-eco","status":"publish","type":"post","link":"https:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/","title":{"rendered":"Nouvelle recherche pr\u00e9sent\u00e9e en direct \u00e0 ECO"},"content":{"rendered":"<p>Une nouvelle \u00e9tude comparative entre le tirzepatide et le semaglutide pour la perte de poids chez les personnes souffrant d'ob\u00e9sit\u00e9, mais non de diab\u00e8te, montre qu'au bout de 72 semaines, le tirzepatide entra\u00eene une perte de poids moyenne de 20,21 TP3T, soit 471 TP3T de plus que la perte de poids moyenne de 13,71 TP3T obtenue avec le semaglutide. Cette \u00e9tude, pr\u00e9sent\u00e9e lors du Congr\u00e8s europ\u00e9en sur l'ob\u00e9sit\u00e9 qui s'est tenu cette ann\u00e9e \u00e0 Malaga, en Espagne (du 11 au 14 mai), et publi\u00e9e dans le NEJM, a \u00e9t\u00e9 men\u00e9e par le Dr Louis J. Aronne, du Comprehensive Weight Control Center, Weill Cornell Medicine, New York, New York, \u00c9tats-Unis, et ses coll\u00e8gues.<\/p>\n<ul>\n<li><a href=\"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/NEJM-v3-12052025.pdf\" target=\"_blank\" rel=\"noopener\">Lire le communiqu\u00e9 de presse complet<\/a><\/li>\n<li><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2416394\" target=\"_blank\" rel=\"noopener\">Lire l'article sous embargo<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20.2%, 47% higher than the 13.7% average weight loss for semaglutide. The study, presented at this year\u2019s European Congress on Obesity in Malaga, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":128256,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[68,460],"tags":[],"class_list":["post-128253","post","type-post","status-publish","has-post-thumbnail","hentry","category-eco","category-research"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Research presented live at ECO - EASO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Research presented live at ECO - EASO\" \/>\n<meta property=\"og:description\" content=\"A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20.2%, 47% higher than the 13.7% average weight loss for semaglutide. The study, presented at this year\u2019s European Congress on Obesity in Malaga, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/\" \/>\n<meta property=\"og:site_name\" content=\"EASO\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-12T04:00:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"EASO Secretariat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EASO Secretariat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/\"},\"author\":{\"name\":\"EASO Secretariat\",\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\"},\"headline\":\"New Research presented live at ECO\",\"datePublished\":\"2025-05-12T04:00:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/\"},\"wordCount\":94,\"commentCount\":0,\"image\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/new-research-presented.jpg\",\"articleSection\":[\"ECO\",\"Research\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/\",\"url\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/\",\"name\":\"New Research presented live at ECO - EASO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/easo.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#primaryimage\"},\"image\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/new-research-presented.jpg\",\"datePublished\":\"2025-05-12T04:00:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#primaryimage\",\"url\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/new-research-presented.jpg\",\"contentUrl\":\"https:\\\/\\\/easo.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/new-research-presented.jpg\",\"width\":700,\"height\":400,\"caption\":\"Slide announces ECO research showing tirzepatide leads to about 50% more weight loss than semaglutide in people with obesity; includes EASO and European Congress on Obesity logos.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/easo.org\\\/fr\\\/new-research-presented-live-at-eco\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/easo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Research presented live at ECO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/easo.org\\\/#website\",\"url\":\"https:\\\/\\\/easo.org\\\/\",\"name\":\"EASO\",\"description\":\"The European Association for the Study of Obesity\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/easo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/easo.org\\\/#\\\/schema\\\/person\\\/df04141f0799503a007288b3899de859\",\"name\":\"EASO Secretariat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g\",\"caption\":\"EASO Secretariat\"},\"url\":\"https:\\\/\\\/easo.org\\\/fr\\\/author\\\/chris\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Research presented live at ECO - EASO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/","og_locale":"fr_FR","og_type":"article","og_title":"New Research presented live at ECO - EASO","og_description":"A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an average weight loss of 20.2%, 47% higher than the 13.7% average weight loss for semaglutide. The study, presented at this year\u2019s European Congress on Obesity in Malaga, [&hellip;]","og_url":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/","og_site_name":"EASO","article_published_time":"2025-05-12T04:00:26+00:00","og_image":[{"width":700,"height":400,"url":"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg","type":"image\/jpeg"}],"author":"EASO Secretariat","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EASO Secretariat","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#article","isPartOf":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/"},"author":{"name":"EASO Secretariat","@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859"},"headline":"New Research presented live at ECO","datePublished":"2025-05-12T04:00:26+00:00","mainEntityOfPage":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/"},"wordCount":94,"commentCount":0,"image":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#primaryimage"},"thumbnailUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg","articleSection":["ECO","Research"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#respond"]}]},{"@type":"WebPage","@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/","url":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/","name":"New Research presented live at ECO - EASO","isPartOf":{"@id":"https:\/\/easo.org\/#website"},"primaryImageOfPage":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#primaryimage"},"image":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#primaryimage"},"thumbnailUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg","datePublished":"2025-05-12T04:00:26+00:00","author":{"@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859"},"breadcrumb":{"@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#primaryimage","url":"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg","contentUrl":"https:\/\/easo.org\/wp-content\/uploads\/2025\/05\/new-research-presented.jpg","width":700,"height":400,"caption":"Slide announces ECO research showing tirzepatide leads to about 50% more weight loss than semaglutide in people with obesity; includes EASO and European Congress on Obesity logos."},{"@type":"BreadcrumbList","@id":"http:\/\/easo.org\/fr\/new-research-presented-live-at-eco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/easo.org\/"},{"@type":"ListItem","position":2,"name":"New Research presented live at ECO"}]},{"@type":"WebSite","@id":"https:\/\/easo.org\/#website","url":"https:\/\/easo.org\/","name":"EASO","description":"Association europ\u00e9enne pour l'\u00e9tude de l'ob\u00e9sit\u00e9","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/easo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/easo.org\/#\/schema\/person\/df04141f0799503a007288b3899de859","name":"Secr\u00e9tariat de l'EASO","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0fd7862e576feca270caaf38106c4629cd944118735a6fd5afe95dfe85b68c75?s=96&d=mm&r=g","caption":"EASO Secretariat"},"url":"https:\/\/easo.org\/fr\/author\/chris\/"}]}},"_links":{"self":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/comments?post=128253"}],"version-history":[{"count":1,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128253\/revisions"}],"predecessor-version":[{"id":128255,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/posts\/128253\/revisions\/128255"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/media\/128256"}],"wp:attachment":[{"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/media?parent=128253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/categories?post=128253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/easo.org\/fr\/wp-json\/wp\/v2\/tags?post=128253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}